feed,title,long_url,short_url
SeekingAlpha,Amylyx stock rises 16% as FDA extends review period of ALS drug which failed panel backing,https://seekingalpha.com/news/3845431,
SeekingAlpha,"Duckhorn Portfolio pushes higher on earnings beat, raised guidance",https://seekingalpha.com/news/3845432,
